Columbia University Medical Center
Ranked #1 in Psychiatry
U.S. News & World Report
Ranked #1 in Research Funding
National Institutes of Health
NewYork-Presbyterian Hospital The University Hospital of Columbia and Cornell

Ketamine for Major Depression

Study Name: Ketamine for Major Depression

Principal Investigator: J. John Mann, M.D.

Purpose of Study: To determine how ketamine, a new experimental treatment, works as an antidepressant by using MRI scanning (no radiation involved) during the actual ketamine treatment of 40 minutes and for a short time afterwards. When effective, ketamine generally works in as little as four hours.

Treatment Offered: One dose of ketamine followed by an oral medication called riluzole for 8 weeks to maintain benefit in those whose depression responds to ketamine

Eligibility: A diagnosis of major depression and a history of any kind treatment for depression at any point in the past.

Funding: The Brain and Behavior Foundation

Contact information: Shayna Friedman
Phone: 646-774-5788


hora interior